Use of zoledronic acid therapy–associated severe hypophosphatemia to identify poor-prognosis patients with metastatic castration-resistant prostate cancer.
Julia Warr
No relevant relationships to disclose
David Yam
No relevant relationships to disclose
Shannon Goodall
No relevant relationships to disclose
Leah VanDraanen
No relevant relationships to disclose
Angie Giotis
No relevant relationships to disclose
Mark Pasetka
No relevant relationships to disclose
Carlo De Angelis
No relevant relationships to disclose
Urban Emmenegger
No relevant relationships to disclose